top of page

390 results found with an empty search

  • Remodeling Capacity | Orthorico

    < Back Remodeling Capacity remodeling-capacity Previous Next

  • Basilar Thumb Arthritis | Orthorico

    < Back Basilar Thumb Arthritis basillar-thumb-arthritis Previous Next

  • Privacy Policy | Orthorico

    Privacy Policy Effective Date: 20.06.2025 OrthoRico (“we”, “our”, or “us”) is committed to protecting the privacy of our users. This Privacy Policy explains how we collect, use, store, and protect your personal information when you visit and use orthorico.com. 1. Information We Collect We may collect the following types of personal data: Name and email address (during account registration) Google or Facebook public profile information (if used to sign in) Professional background (e.g., medical specialty) Usage data (e.g., pages visited, time spent, device type) 2. How We Use Your Information We use your data to: Create and manage your member profile Customize your experience and improve our content Send newsletters and updates (if subscribed) Monitor and improve site performance (via analytics tools) 3. Data Sharing and Third Parties We do not sell or rent your personal data. However, your data may be shared with trusted service providers such as: Wix.com (hosting and membership system) Google Analytics (usage statistics) Authentication services (Google, Facebook) All providers are required to protect your data and comply with GDPR. 4. Cookies OrthoRico uses cookies to improve user experience and analyze traffic. You may control or delete cookies through your browser settings. 5. Your Rights You have the right to: Access the personal data we store about you Correct or delete your information Withdraw your consent at any time Request that your account and data be deleted by contacting us at [your email] 6. Data Security Your data is stored on secure servers provided by Wix.com. We take reasonable steps to protect your information from unauthorized access or disclosure. 7. Children’s Privacy Our site is intended for medical professionals only and is not directed to individuals under 18. 8. Changes to This Policy We may update this policy periodically. All changes will be posted on this page with a revised “Effective Date.” 9. Contact Us If you have any questions or requests regarding your privacy, please contact us at: 📧 [orthoricoinfo@gmail.com]

  • Kienböck’s Disease | Orthorico

    < Back Kienböck’s Disease kienbocks-disease Previous Next

  • Hand & Fingers | Orthorico

    < Back Hand & Fingers Injuries to the hand and fingers are common and vary from simple lacerations and fractures to complex tendon and joint injuries. Accurate diagnosis and timely management are crucial to preserve function. Hand and finger trauma encompasses a wide spectrum, including phalangeal fractures, dislocations, tendon lacerations (flexor/extensor), and nail bed injuries. Mechanisms include crush injuries, direct blows, and lacerations. Initial assessment includes inspection for deformity, neurovascular status, range of motion, and tendon function. Radiographs are essential to evaluate fractures or joint dislocations. Common injuries: Mallet finger Jersey finger Boutonnière and swan-neck deformities Metacarpal neck (Boxer’s) fracture Open fractures (risk of infection) Treatment varies: from splinting and buddy taping to surgical fixation or tendon repair. Rehabilitation and early motion are vital to prevent stiffness. hand-fingers Previous Next

  • Anticoagulants | Orthorico

    < Back Anticoagulants Anticoagulants are medications that prevent clot formation. They are essential in orthopaedics for thromboprophylaxis, especially after surgery. Common Anticoagulants in Orthopaedics: Low Molecular Weight Heparin (LMWH): Enoxaparin Direct Oral Anticoagulants (DOACs): Rivaroxaban, Apixaban, Dabigatran Unfractionated Heparin Warfarin (less common due to monitoring needs) Indications in Orthopaedics: Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) after joint replacement or major trauma Management of patients with a history of thromboembolism Atrial fibrillation with orthopaedic comorbidities Key Considerations: Start prophylaxis 6–12 hours after surgery (depending on bleeding risk) Continue for at least 10–14 days, sometimes up to 35 days in hip replacement Adjust dosing for renal function Monitor for signs of bleeding (wound hematoma, prolonged bleeding) Contraindications: Active bleeding Severe bleeding risk (e.g., recent CNS surgery) Coagulopathy Bridging and Reversal: Reversal agents: Protamine (heparin), Vitamin K (warfarin), Idarucizumab (dabigatran) Bridging required with LMWH in warfarin patients undergoing surgery Previous Next

  • Scheuermann’s Kyphosis | Orthorico

    < Back Scheuermann’s Kyphosis Previous Next

  • Congenital Scoliosis | Orthorico

    < Back Congenital Scoliosis Previous Next

  • Lumbar Spine Fractures | Orthorico

    < Back Lumbar Spine Fractures kocaelispor Previous Next

  • Orthoplastic Approach in Open Fractures | Orthorico

    < Back Orthoplastic Approach in Open Fractures orthoplastic-approach-open-fractures Previous Next

  • Terms of Use | Orthorico

    Terms of Use Effective Date: 20.06.2025 Welcome to OrthoRico. By accessing or using this website (orthorico.com), you agree to the following Terms of Use. If you do not agree, please do not use the site. 1. Eligibility OrthoRico is intended for licensed medical professionals and trainees. By registering, you confirm that you are a physician, orthopaedic surgeon, resident, or a healthcare professional. 2. Account and Membership You are responsible for maintaining the confidentiality of your login credentials. You agree not to share your account or impersonate another person. We reserve the right to suspend or terminate accounts that violate our policies. 3. Content Usage All content (text, images, surgical guides) is for educational purposes only. No content may be copied, downloaded, redistributed, or used for commercial purposes without prior permission. OrthoRico does not provide medical advice or replace clinical judgment. 4. Contributor Submissions Contributors retain the rights to their original content but grant OrthoRico a license to display, modify, or distribute it on the site. You must ensure submitted content is accurate, respectful, and does not infringe any rights. 5. Limitation of Liability We do our best to provide accurate information, but we do not guarantee completeness or reliability. OrthoRico is not liable for any decisions made based on site content. 6. Modifications We reserve the right to modify these Terms at any time. Continued use of the site means you accept the updated terms. 7. Contact For questions or concerns regarding these Terms, email us at: 📧 [orthoricoinfo@gmail.com]

  • Endoprosthesis | Orthorico

    < Back Dr. Serkan BAYRAM Endoprosthesis Endoprosthetic reconstruction is a cornerstone technique in musculoskeletal oncology, allowing immediate restoration of skeletal continuity and early mobilization after wide tumor resection. Modern modular megaprostheses, made of titanium or cobalt-chromium alloys, are designed for durability, functional recovery, and ease of revision. They are primarily indicated for periarticular or diaphyseal bone loss following tumor excision, failed fixation, or pathological fractures. Cemented fixation ensures immediate stability, while press-fit and porous-coated designs promote biological integration. Despite excellent limb salvage rates (>90%), complications such as infection, aseptic loosening, and mechanical failure remain challenges. Advances including silver-coated implants, expandable pediatric prostheses, and improved soft-tissue reattachment techniques continue to enhance long-term outcomes and quality of life for oncology patients. Definition An endoprosthesis is a modular metallic implant used to reconstruct bone and joint defects following wide resection of primary or metastatic musculoskeletal tumors. The aim is to achieve immediate structural stability , preserve limb function, and allow early mobilization, particularly in cases where biological reconstruction (allograft or autograft) is not feasible. Indications Segmental bone loss after tumor resection, particularly in the proximal humerus , distal femur , and proximal tibia . Periarticular destruction due to primary bone sarcomas (e.g., osteosarcoma, Ewing sarcoma) or metastatic disease. Reconstruction after pathological fractures or failed fixation in oncologic bone. Salvage after infection or mechanical failure of previous reconstruction. Design and Components Modern tumor prostheses are modular megaprostheses made from titanium or cobalt-chromium alloys, often with: Cemented or press-fit stems for fixation into the remaining diaphysis. Rotating hinge joints (knee and elbow) to reduce torque and wear. Porous-coated or hydroxyapatite collars to promote soft-tissue and bone integration. Expandable designs for skeletally immature patients, allowing non-invasive limb-length adjustment. Cemented fixation offers immediate stability, while cementless (press-fit) fixation supports long-term biological fixation and easier revision. Surgical Principles Wide oncologic margins are mandatory to minimize local recurrence. Preservation of neurovascular structures and soft-tissue coverage is essential. Stable fixation and restoration of limb length should be achieved intraoperatively. Reconstruction of muscle attachments (especially in proximal humerus and tibia) improves functional outcome. Prophylactic antibiotic cement or silver-coated implants are used to reduce infection risk in high-risk cases. Advantages Immediate load-bearing capability. Shorter operative time compared to biological reconstructions. Predictable early function and pain relief. Can be revised modularly if components wear or fracture. Complications Infection (5–15%); more common in immunocompromised or irradiated patients. Mechanical failure (loosening, stem breakage). Aseptic loosening due to stress shielding. Periprosthetic fracture and soft-tissue failure (e.g., extensor mechanism insufficiency). Outcomes and Prognosis Endoprosthetic reconstructions provide excellent pain relief and limb salvage rates exceeding 90% in modern series. Five-year implant survival is around 70–80% , depending on site and indication. Long-term durability is enhanced by improved modular designs, better fixation strategies, and multidisciplinary care. References Rizzo SE, Kenan S. Pathologic Fractures. StatPearls Publishing, 2025. Fields RC et al. Management of Pathological Fractures: Current Consensus. Knee Surg Sports Traumatol Arthrosc , 2024. Boussouar S et al. Tailored Approach for Appendicular Pathologic Fractures from Metastatic Bone Disease. Cancers (Basel) , 2022. Jeys L, Grimer R. Endoprosthetic Reconstruction After Tumor Resection. J Bone Joint Surg Br , 2019. Henderson ER et al. Failure Mode Classification for Tumor Endoprostheses: An International Consensus. Clin Orthop Relat Res , 2017. Quick Facts Feature Details Purpose Reconstruction of segmental bone or joint defects after tumor resection Main Indications Primary or metastatic bone tumors, failed fixation, post-infection salvage Common Sites Distal femur, proximal tibia, proximal humerus, proximal femur Design Type Modular or custom-made megaprostheses (cemented or press-fit fixation) Expandable Prostheses Used in skeletally immature patients to allow limb-length adjustment Key Materials Titanium, cobalt-chromium alloys, silver-coated or hydroxyapatite collars Advantages Immediate stability, early mobilization, predictable limb function Common Complications Infection (5–15%), aseptic loosening, mechanical failure, periprosthetic fracture Functional Outcome Limb salvage rate >90%; 5-year implant survival 70–80% Preferred in Large bone defects or periarticular resections where biological grafting is not feasible Previous Next

bottom of page